Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H29FN2O3 |
Molecular Weight | 363.4568 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CCC[18F])=CC(C(=O)NC[C@@H]2CCCN2CC=C)=C1OC
InChI
InChIKey=OABRYNHZQBZDMG-DLGGVWGKSA-N
InChI=1S/C20H29FN2O3/c1-4-10-23-11-6-8-16(23)14-22-20(24)17-12-15(7-5-9-21)13-18(25-2)19(17)26-3/h4,12-13,16H,1,5-11,14H2,2-3H3,(H,22,24)/t16-/m0/s1/i21-1
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. | 1995 Apr |
|
Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. | 2002 Dec 1 |
|
Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies. | 2015 Dec |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ZF3G9J6G7I
Created by
admin on Fri Dec 15 15:37:26 GMT 2023 , Edited by admin on Fri Dec 15 15:37:26 GMT 2023
|
PRIMARY | |||
|
166173-82-6
Created by
admin on Fri Dec 15 15:37:26 GMT 2023 , Edited by admin on Fri Dec 15 15:37:26 GMT 2023
|
PRIMARY | |||
|
449762
Created by
admin on Fri Dec 15 15:37:26 GMT 2023 , Edited by admin on Fri Dec 15 15:37:26 GMT 2023
|
PRIMARY |
ACTIVE MOIETY